Genetics basis for GnRH-dependent pubertal disorders in humans

Molecular and Cellular Endocrinology

Volumn 324, Issue 1-2, 2010, Pages 30-38

  Silveira, Leticia Ferreira Gontijo ^a   Trarbach, Ericka Barbosa ^a   Latronico, Ana Claudia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Central precocious puberty; GnRH neurons; Isolated hypogonadotropic hypogonadism; Kallmann syndrome; Kisspeptin

Indexed keywords

DNA BINDING PROTEIN; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR 1; G PROTEIN COUPLED RECEPTOR 54; GONADORELIN; GONADORELIN RECEPTOR; KISSPEPTIN; METASTIN; NEUROKININ 3 RECEPTOR; NEUROKININ B;

ANOSMIA; ARCUATE NUCLEUS; CHROMOSOME 19; FRAMESHIFT MUTATION; GENETIC HETEROGENEITY; GONADORELIN RELEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; KALLMANN SYNDROME; LINKAGE ANALYSIS; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; PATHOGENESIS; PHENOTYPIC VARIATION; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PUBERTY DISORDERS; REVIEW; SYNDROME CHARGE; DISORDER OF SEX DEVELOPMENT; GENETICS; INHERITANCE; METABOLISM; PUBERTY;

DISORDERS OF SEX DEVELOPMENT; GONADOTROPIN-RELEASING HORMONE; HUMANS; INHERITANCE PATTERNS; PUBERTY; PUBERTY, PRECOCIOUS;

EID: 77953880509     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.02.023     Document Type: Review

References (125)

1. Abreu A.P., Trarbach E.B., de Castro M., Frade Costa E.M., Versiani B., Matias Baptista M.T., Garmes H.M., Mendonca B.B., Latronico A.C. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J. Clin. Endocrinol. Metab. 2008, 93:4113-4118.
2. Ballabio A., Bardoni B., Carrozzo R., Andria G., Bick D., Campbell L., Hamel B., Ferguson-Smith M.A., Gimelli G., Fraccaro M., et al. Contiguous gene syndromes due to deletions in the distal short arm of the human X chromosome. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:10001-10005.
3. Beranova M., Oliveira L.M., Bedecarrats G.Y., Schipani E., Vallejo M., Ammini A.C., Quintos J.B., Hall J.E., Martin K.A., Hayes F.J., Pitteloud N., Kaiser U.B., Crowley W.F., Seminara S.B. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 2001, 86:1580-1588.
4. Bouligand J., Ghervan C., Tello J.A., Brailly-Tabard S., Salenave S., Chanson P., Lombes M., Millar R.P., Guiochon-Mantel A., Young J. Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N. Engl. J. Med. 2009, 360:2742-2748.
5. Brito V.N., Latronico A.C., Arnhold I.J., Mendonca B.B. Update on the etiology, diagnosis and therapeutic management of sexual precocity. Arq. Bras. Endocrinol. Metabol. 2008, 52:18-31.
6. Bulow H.E., Berry K.L., Topper L.H., Peles E., Hobert O. Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:6346-6351.
7. Canto P., Munguia P., Soderlund D., Castro J.J., Mendez J.P. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1. J. Androl. 2009, 30:41-45.
8. Carel J.C., Leger J. Clinical practice. Precocious puberty. N. Engl. J. Med. 2008, 358:2366-2377.
9. Cariboni A., Pimpinelli F., Colamarino S., Zaninetti R., Piccolella M., Rumio C., Piva F., Rugarli E.I., Maggi R. The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. Hum. Mol. Genet. 2004, 13:2781-2791.
10. Castano J.P., Martinez-Fuentes A.J., Gutierrez-Pascual E., Vaudry H., Tena-Sempere M., Malagon M.M. Intracellular signaling pathways activated by kisspeptins through GPR54: Do multiple signals underlie function diversity?. Peptides 2008.
11. Chan Y.M., de Guillebon A., Lang-Muritano M., Plummer L., Cerrato F., Tsiaras S., Gaspert A., Lavoie H.B., Wu C.H., Crowley W.F., Amory J.K., Pitteloud N., Seminara S.B. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:11703-11708.
12. Chung W.C., Moyle S.S., Tsai P.S. Fibroblast growth factor 8 signaling through fibroblast growth factor receptor 1 is required for the emergence of gonadotropin-releasing hormone neurons. Endocrinology 2008, 149:4997-5003.
13. Cole L.W., Sidis Y., Zhang C., Quinton R., Plummer L., Pignatelli D., Hughes V.A., Dwyer A.A., Raivio T., Hayes F.J., Seminara S.B., Huot C., Alos N., Speiser P., Takeshita A., Van Vliet G., Pearce S., Crowley W.F., Zhou Q.Y., Pitteloud N. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J. Clin. Endocrinol. Metab. 2008, 93:3551-3559.
14. Colledge W.H. Transgenic mouse models to study Gpr54/kisspeptin physiology. Peptides 2008.
15. Conn P.M., Janovick J.A. Trafficking and quality control of the gonadotropin releasing hormone receptor in health and disease. Mol. Cell. Endocrinol. 2009, 299:137-145.
16. Costa E.M., Bedecarrats G.Y., Mendonca B.B., Arnhold I.J., Kaiser U.B., Latronico A.C. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction. J. Clin. Endocrinol. Metab. 2001, 86:2680-2686.
17. d'Anglemont de Tassigny X., Fagg L.A., Dixon J.P., Day K., Leitch H.G., Hendrick A.G., Zahn D., Franceschini I., Caraty A., Carlton M.B., Aparicio S.A., Colledge W.H. Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:10714-10719.
18. de Brito V.N., Latronico A.C., Arnhold I.J., Lo L.S., Domenice S., Albano M.C., Fragoso M.C., Mendonca B.B. Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot. Arch. Dis. Child. 1999, 80:231-234.
19. De Morsier G. Etudes sur les dysraphies cranio-encephaliques. I. Agenesie des lobes olfactifs (telencephaloschizis lateral) et des commissures calleuse et anterieure (telencephaloschizis median): la dysplasie olfacto-genitale. Schweiz. Arch. Neurol. Psychiat. 1954, 74:309-361.
20. de Roux N., Young J., Misrahi M., Genet R., Chanson P., Schaison G., Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Engl. J. Med. 1997, 337:1597-1602.
21. de Roux N., Genin E., Carel J.C., Matsuda F., Chaussain J.L., Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:10972-10976.
22. de Vries L., Kauschansky A., Shohat M., Phillip M. Familial central precocious puberty suggests autosomal dominant inheritance. J. Clin. Endocrinol. Metab. 2004, 89:1794-1800.
23. Dhillo W.S., Chaudhri O.B., Patterson M., Thompson E.L., Murphy K.G., Badman M.K., McGowan B.M., Amber V., Patel S., Ghatei M.A., Bloom S.R. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J. Clin. Endocrinol. Metab. 2005, 90:6609-6615.
24. Dode C., Levilliers J., Dupont J.M., De Paepe A., Le Du N., Soussi-Yanicostas N., Coimbra R.S., Delmaghani S., Compain-Nouaille S., Baverel F., Pecheux C., Le Tessier D., Cruaud C., Delpech M., Speleman F., Vermeulen S., Amalfitano A., Bachelot Y., Bouchard P., Cabrol S., Carel J.C., Delemarre-van de Waal H., Goulet-Salmon B., Kottler M.L., Richard O., Sanchez-Franco F., Saura R., Young J., Petit C., Hardelin J.P. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat. Genet. 2003, 33:463-465.
25. Dode C., Teixeira L., Levilliers J., Fouveaut C., Bouchard P., Kottler M.L., Lespinasse J., Lienhardt-Roussie A., Mathieu M., Moerman A., Morgan G., Murat A., Toublanc J.E., Wolczynski S., Delpech M., Petit C., Young J., Hardelin J.P. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2006, 2:e175.
26. Duke V.M., Winyard P.J., Thorogood P., Soothill P., Bouloux P.M., Woolf A.S. KAL, a gene mutated in Kallmann's syndrome, is expressed in the first trimester of human development. Mol. Cell. Endocrinol. 1995, 110:73-79.
27. Falardeau J., Chung W.C., Beenken A., Raivio T., Plummer L., Sidis Y., Jacobson-Dickman E.E., Eliseenkova A.V., Ma J., Dwyer A., Quinton R., Na S., Hall J.E., Huot C., Alois N., Pearce S.H., Cole L.W., Hughes V., Mohammadi M., Tsai P., Pitteloud N. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J. Clin. Invest. 2008, 118:2822-2831.
28. Franco B., Guioli S., Pragliola A., Incerti B., Bardoni B., Tonlorenzi R., Carrozzo R., Maestrini E., Pieretti M., Taillon-Miller P., et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991, 353:529-536.
29. Freitas K.C., Ryan G., Brito V.N., Tao Y.X., Costa E.M., Mendonca B.B., Segaloff D., Latronico A.C. Molecular analysis of the neuropeptide Y1 receptor gene in human idiopathic gonadotropin-dependent precocious puberty and isolated hypogonadotropic hypogonadism. Fertil. Steril. 2007, 87:627-634.
30. Funes S., Hedrick J.A., Vassileva G., Markowitz L., Abbondanzo S., Golovko A., Yang S., Monsma F.J., Gustafson E.L. The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem. Biophys. Res. Commun. 2003, 312:1357-1363.
31. Georgopoulos N., Pralong F., Seidman C., Seidman J., Crowley W.J., Vallejo M. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency. J. Clin. Endocrinol. Metab. 1997, 82:213-217.
32. Gianetti, E., Tusset, C., Noel, S.D., Au, M.G., Dwyer, A.A., Hughes, V.A., Abreu, A.P., Carroll, J., Trarbach, E., Silveira, L.F.G., Costa, E.M.F., Mendonça, B.B., de Castro, M., Lofrano, A., Hall, J.E., Bolu, E., Ozata, M., Quinton, R., Amory, J.K., Stewart, S.E., Arlt, W., Cole, T.R., Crowley, W.F., Kaiser, U.B., Latronico, A.C., Seminara, S.B., in press. TAC3/TACR3 Mutations reveal preferential activation of GnRH release 1 by neurokinin B in neonatal life followed by reversal in adulthood. J. Clin. Endocrinol. Metab.
33. Gonzalez-Martinez D., Hu Y., Bouloux P.M. Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome. Front. Neuroendocrinol. 2004, 25:108-130.
34. Goodman R.L., Lehman M.N., Smith J.T., Coolen L.M., de Oliveira C.V., Jafarzadehshirazi M.R., Pereira A., Iqbal J., Caraty A., Ciofi P., Clarke I.J. Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B. Endocrinology 2007, 148:5752-5760.
35. Gottsch M.L., Cunningham M.J., Smith J.T., Popa S.M., Acohido B.V., Crowley W.F., Seminara S., Clifton D.K., Steiner R.A. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 2004, 145:4073-4077.
36. Gottsch M.L., Clifton D.K., Steiner R.A. Galanin-like peptide as a link in the integration of metabolism and reproduction. Trends Endocrinol. Metab. 2004, 15:215-221.
37. Grumbach M.M. The neuroendocrinology of human puberty revisited. Horm. Res. 2002, 57(Suppl. 2):2-14.
38. Guran T., Tolhurst G., Bereket A., Rocha N., Porter K., Turan S., Gribble F.M., Kotan L.D., Akcay T., Atay Z., Canan H., Serin A., O'Rahilly S., Reimann F., Semple R.K., Topaloglu A.K. Hypogonadotropic hypogonadism due to a novel missense mutation in the first extracellular loop of the neurokinin B receptor. J. Clin. Endocrinol. Metab. 2009, 94:3633-3639.
39. Han S.K., Gottsch M.L., Lee K.J., Popa S.M., Smith J.T., Jakawich S.K., Clifton D.K., Steiner R.A., Herbison A.E. Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J. Neurosci. 2005, 25:11349-11356.
40. He C., Kraft P., Chen C., Buring J.E., Pare G., Hankinson S.E., Chanock S.J., Ridker P.M., Hunter D.J., Chasman D.I. Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat. Genet. 2009.
41. Higgs D.R., Vernimmen D., Hughes J., Gibbons R. Using genomics to study how chromatin influences gene expression. Annu. Rev. Genomics Hum. Genet. 2007, 8:299-325.
42. Ibrahimi O.A., Zhang F., Hrstka S.C., Mohammadi M., Linhardt R.J. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry 2004, 43:4724-4730.
43. Jongmans M.C., van Ravenswaaij-Arts C.M., Pitteloud N., Ogata T., Sato N., Claahsen-van der Grinten H.L., van der Donk K., Seminara S., Bergman J.E., Brunner H.G., Crowley W.F., Hoefsloot L.H. CHD7 mutations in patients initially diagnosed with Kallmann syndrome-the clinical overlap with CHARGE syndrome. Clin. Genet. 2009, 75:65-71.
44. Kakar S.S., Musgrove L.C., Devor D.C., Sellers J.C., Neill J.D. Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem. Biophys. Res. Commun. 1992, 189:289-295.
45. Kakarla N., Bradshaw K.D. Disorders of pubertal development: precocious puberty. Semin. Reprod. Med. 2003, 21:339-351.
46. Kallmann F.J., Schoenfeld W.A., Barrera S.E. The genetic aspects of primary eunuchoidism. Am. J. Ment. Defic. 1944, 48:203-236.
47. Kim H.G., Kurth I., Lan F., Meliciani I., Wenzel W., Eom S.H., Kang G.B., Rosenberger G., Tekin M., Ozata M., Bick D.P., Sherins R.J., Walker S.L., Shi Y., Gusella J.F., Layman L.C. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 2008, 83:511-519.
48. Kotani M., Detheux M., Vandenbogaerde A., Communi D., Vanderwinden J.M., Le Poul E., Brezillon S., Tyldesley R., Suarez-Huerta N., Vandeput F., Blanpain C., Schiffmann S.N., Vassart G., Parmentier M. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J. Biol. Chem. 2001, 276:34631-34636.
49. Kottler M.L., Counis R., Bouchard P. Mutations of the GnRH receptor gene: a new cause of autosomal-recessive hypogonadotropic hypogonadism. Arch. Med. Res. 1999, 30:481-485.
50. Krajewski S.J., Anderson M.J., Iles-Shih L., Chen K.J., Urbanski H.F., Rance N.E. Morphologic evidence that neurokinin B modulates gonadotropin-releasing hormone secretion via neurokinin 3 receptors in the rat median eminence. J. Comp. Neurol. 2005, 489:372-386.
51. Lanfranco F., Gromoll J., von Eckardstein S., Herding E.M., Nieschlag E., Simoni M. Role of sequence variations of the GnRH receptor and G protein-coupled receptor 54 gene in male idiopathic hypogonadotropic hypogonadism. Eur. J. Endocrinol. 2005, 153:845-852.
52. Lapatto R., Pallais J.C., Zhang D., Chan Y.M., Mahan A., Cerrato F., Le W.W., Hoffman G.E., Seminara S.B. Kiss1-/- mice exhibit more variable hypogonadism than Gpr54-/- mice. Endocrinology 2007, 148:4927-4936.
53. Layman L.C., Cohen D.P., Jin M., Xie J., Li Z., Reindollar R.H., Bolbolan S., Bick D.P., Sherins R.R., Duck L.W., Musgrove L.C., Sellers J.C., Neill J.D. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat. Genet. 1998, 18:14-15.
54. Lee D.K., Nguyen T., O'Neill G.P., Cheng R., Liu Y., Howard A.D., Coulombe N., Tan C.P., Tang-Nguyen A.T., George S.R., O'Dowd B.F. Discovery of a receptor related to the galanin receptors. FEBS Lett. 1999, 446:103-107.
55. Legouis R., Hardelin J.P., Levilliers J., Claverie J.M., Compain S., Wunderle V., Millasseau P., Le Paslier D., Cohen D., Caterina D., et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991, 67:423-435.
56. Lin L., Conway G.S., Hill N.R., Dattani M.T., Hindmarsh P.C., Achermann J.C. A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor (GNRHR) presenting as constitutional delay of growth and puberty with subsequent borderline oligospermia. J. Clin. Endocrinol. Metab. 2006.
57. Lutz B., Kuratani S., Rugarli E.I., Wawersik S., Wong C., Bieber F.R., Ballabio A., Eichele G. Expression of the Kallmann syndrome gene in human fetal brain and in the manipulated chick embryo. Hum. Mol. Genet. 1994, 3:1717-1723.
58. Maestre de San Juan A. Teratolagia: falta total de los nervios olfactorios con anosmia en un individuo en quien existia una atrofia congenita de los testiculos y miembro viril. El Siglo Med. 1856, 3:211-221.
59. Masumoto K.H., Nagano M., Takashima N., Hayasaka N., Hiyama H., Matsumoto S., Inouye S.T., Shigeyoshi Y. Distinct localization of prokineticin 2 and prokineticin receptor 2 mRNAs in the rat suprachiasmatic nucleus. Eur. J. Neurosci. 2006, 23:2959-2970.
60. Matsui H., Takatsu Y., Kumano S., Matsumoto H., Ohtaki T. Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem. Biophys. Res. Commun. 2004, 320:383-388.
61. Mayston M.J., Harrison L.M., Quinton R., Stephens J.A., Krams M., Bouloux P.M. Mirror movements in X-linked Kallmann's syndrome. I. A neurophysiological study. Brain 1997, 120(Pt 7):1199-1216.
62. McKeehan W.L., Kan M. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships. Mol. Reprod. Dev. 1994, 39:69-81. discussion 81-2.
63. Messager S., Chatzidaki E.E., Ma D., Hendrick A.G., Zahn D., Dixon J., Thresher R.R., Malinge I., Lomet D., Carlton M.B., Colledge W.H., Caraty A., Aparicio S.A. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1761-1766.
64. Meyers E.N., Lewandoski M., Martin G.R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 1998, 18:136-141.
65. Meysing A.U., Kanasaki H., Bedecarrats G.Y., Acierno J.S., Conn P.M., Martin K.A., Seminara S.B., Hall J.E., Crowley W.F., Kaiser U.B. GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone. J. Clin. Endocrinol. Metab. 2004, 89:3189-3198.
66. Miura K., Acierno J.S., Seminara S.B. Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH). J. Hum. Genet. 2004, 49:265-268.
67. Monnier C., Dode C., Fabre L., Teixeira L., Labesse G., Pin J.P., Hardelin J.P., Rondard P. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity. Hum. Mol. Genet. 2009, 18:75-81.
68. Muir A.I., Chamberlain L., Elshourbagy N.A., Michalovich D., Moore D.J., Calamari A., Szekeres P.G., Sarau H.M., Chambers J.K., Murdock P., Steplewski K., Shabon U., Miller J.E., Middleton S.E., Darker J.G., Larminie C.G., Wilson S., Bergsma D.J., Emson P., Faull R., Philpott K.L., Harrison D.C. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J. Biol. Chem. 2001, 276:28969-28975.
69. Navarro V.M., Fernandez-Fernandez R., Castellano J.M., Roa J., Mayen A., Barreiro M.L., Gaytan F., Aguilar E., Pinilla L., Dieguez C., Tena-Sempere M. Advanced vaginal opening and precocious activation of the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54. J. Physiol. 2004, 561:379-386.
70. Navarro V.M., Castellano J.M., Fernandez-Fernandez R., Tovar S., Roa J., Mayen A., Nogueiras R., Vazquez M.J., Barreiro M.L., Magni P., Aguilar E., Dieguez C., Pinilla L., Tena-Sempere M. Characterization of the potent luteinizing hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology 2005, 146:156-163.
71. Navarro V.M., Castellano J.M., Garcia-Galiano D., Tena-Sempere M. Neuroendocrine factors in the initiation of puberty: the emergent role of kisspeptin. Rev. Endocr. Metab. Disord. 2007, 8:11-20.
72. Ohtaki T., Shintani Y., Honda S., Matsumoto H., Hori A., Kanehashi K., Terao Y., Kumano S., Takatsu Y., Masuda Y., Ishibashi Y., Watanabe T., Asada M., Yamada T., Suenaga M., Kitada C., Usuki S., Kurokawa T., Onda H., Nishimura O., Fujino M. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001, 411:613-617.
73. Oliveira L.M., Seminara S.B., Beranova M., Hayes F.J., Valkenburgh S.B., Schipani E., Costa E.M., Latronico A.C., Crowley W.F., Vallejo M. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J. Clin. Endocrinol. Metab. 2001, 86:1532-1538.
74. Ong K.K., Elks C.E., Li S., Zhao J.H., Luan J., Andersen L.B., Bingham S.A., Brage S., Smith G.D., Ekelund U., Gillson C.J., Glaser B., Golding J., Hardy R., Khaw K.T., Kuh D., Luben R., Marcus M., McGeehin M.A., Ness A.R., Northstone K., Ring S.M., Rubin C., Sims M.A., Song K., Strachan D.P., Vollenweider P., Waeber G., Waterworth D.M., Wong A., Deloukas P., Barroso I., Mooser V., Loos R.J., Wareham N.J. Genetic variation in LIN28B is associated with the timing of puberty. Nat. Genet. 2009.
75. Pagon R.A., Graham J.M., Zonana J., Yong S.L. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J. Pediatr. 1981, 99:223-227.
76. Palmert M.R., Boepple P.A. Variation in the timing of puberty: clinical spectrum and genetic investigation. J. Clin. Endocrinol. Metab. 2001, 86:2364-2368.
77. Partsch C.J., Heger S., Sippell W.G. Management and outcome of central precocious puberty. Clin. Endocrinol. (Oxf.) 2002, 56:129-148.
78. Pawlowitzki I.H., Diekstall P., Schadel A., Miny P. Estimating frequency of Kallmann syndrome among hypogonadic and among anosmic patients. Am. J. Med. Genet. 1987, 26:473-479.
79. Perantoni A.O., Timofeeva O., Naillat F., Richman C., Pajni-Underwood S., Wilson C., Vainio S., Dove L.F., Lewandoski M. Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development 2005, 132:3859-3871.
80. Perry J.R., Stolk L., Franceschini N., Lunetta K.L., Zhai G., McArdle P.F., Smith A.V., Aspelund T., Bandinelli S., Boerwinkle E., Cherkas L., Eiriksdottir G., Estrada K., Ferrucci L., Folsom A.R., Garcia M., Gudnason V., Hofman A., Karasik D., Kiel D.P., Launer L.J., van Meurs J., Nalls M.A., Rivadeneira F., Shuldiner A.R., Singleton A., Soranzo N., Tanaka T., Visser J.A., Weedon M.N., Wilson S.G., Zhuang V., Streeten E.A., Harris T.B., Murray A., Spector T.D., Demerath E.W., Uitterlinden A.G., Murabito J.M. Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat. Genet. 2009.
81. Pescovitz O.H., Comite F., Hench K., Barnes K., McNemar A., Foster C., Kenigsberg D., Loriaux D.L., Cutler G.B. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. J. Pediatr. 1986, 108:47-54.
82. Pirvola U., Ylikoski J., Trokovic R., Hebert J.M., McConnell S.K., Partanen J. FGFR1 is required for the development of the auditory sensory epithelium. Neuron 2002, 35:671-680.
83. Pitteloud N., Boepple P.A., DeCruz S., Valkenburgh S.B., Crowley W.F., Hayes F.J. The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor. J. Clin. Endocrinol. Metab. 2001, 86:2470-2475.
84. Pitteloud N., Hayes F.J., Boepple P.A., DeCruz S., Seminara S.B., MacLaughlin D.T., Crowley W.F. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 2002, 87:152-160.
85. Pitteloud N., Quinton R., Pearce S., Raivio T., Acierno J., Dwyer A., Plummer L., Hughes V., Seminara S., Cheng Y.Z., Li W.P., Maccoll G., Eliseenkova A.V., Olsen S.K., Ibrahimi O.A., Hayes F.J., Boepple P., Hall J.E., Bouloux P., Mohammadi M., Crowley W. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J. Clin. Invest. 2007, 117:457-463.
86. Pitteloud N., Zhang C., Pignatelli D., Li J.D., Raivio T., Cole L.W., Plummer L., Jacobson-Dickman E.E., Mellon P.L., Zhou Q.Y., Crowley W.F. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17447-17452.
87. Plant T.M., Barker-Gibb M.L. Neurobiological mechanisms of puberty in higher primates. Hum. Reprod. Update 2004, 10:67-77.
88. Plant T.M., Ramaswamy S., Dipietro M.J. Repetitive activation of hypothalamic G protein-coupled receptor 54 with intravenous pulses of kisspeptin in the juvenile monkey (Macaca mulatta) elicits a sustained train of gonadotropin-releasing hormone discharges. Endocrinology 2006, 147:1007-1013.
89. Pralong F.P., Gomez F., Castillo E., Cotecchia S., Abuin L., Aubert M.L., Portmann L., Gaillard R.C. Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor. J. Clin. Endocrinol. Metab. 1999, 84:3811-3816.
90. Quinton R., Duke V.M., Robertson A., Kirk J.M., Matfin G., de Zoysa P.A., Azcona C., MacColl G.S., Jacobs H.S., Conway G.S., Besser M., Stanhope R.G., Bouloux P.M. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin. Endocrinol. (Oxf.) 2001, 55:163-174.
91. Raivio T., Dunkel L. Inverse relationship between serum inhibin B and FSH levels in prepubertal boys with cryptorchidism. Pediatr. Res. 1999, 46:496-500.
92. Raivio T., Falardeau J., Dwyer A., Quinton R., Hayes F.J., Hughes V.A., Cole L.W., Pearce S.H., Lee H., Boepple P., Crowley W.F., Pitteloud N. Reversal of idiopathic hypogonadotropic hypogonadism. N. Engl. J. Med. 2007, 357:863-873.
93. Rice D.P., Rice R., Thesleff I. Fgfr mRNA isoforms in craniofacial bone development. Bone 2003, 33:14-27.
94. Rugarli E.I., Di Schiavi E., Hilliard M.A., Arbucci S., Ghezzi C., Facciolli A., Coppola G., Ballabio A., Bazzicalupo P. The Kallmann syndrome gene homolog in C. elegans is involved in epidermal morphogenesis and neurite branching. Development 2002, 129:1283-1294.
95. Salenave S., Chanson P., Bry H., Pugeat M., Cabrol S., Carel J.C., Murat A., Lecomte P., Brailly S., Hardelin J.P., Dode C., Young J. Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations. J. Clin. Endocrinol. Metab. 2008, 93:758-763.
96. Schwankhaus J.D., Currie J., Jaffe M.J., Rose S.R., Sherins R.J. Neurologic findings in men with isolated hypogonadotropic hypogonadism. Neurology 1989, 39:223-226.
97. Schwanzel-Fukuda M., Bick D., Pfaff D.W. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res. Mol. Brain Res. 1989, 6:311-326.
98. Seminara S.B., Oliveira L.M., Beranova M., Hayes F.J., Crowley W.F. Genetics of hypogonadotropic hypogonadism. J. Endocrinol. Invest. 2000, 23:560-565.
99. Seminara S.B., Beranova M., Oliveira L.M., Martin K.A., Crowley W.F., Hall J.E. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. J. Clin. Endocrinol. Metab. 2000, 85:556-562.
100. Seminara S.B., Messager S., Chatzidaki E.E., Thresher R.R., Acierno J.S., Shagoury J.K., Bo-Abbas Y., Kuohung W., Schwinof K.M., Hendrick A.G., Zahn D., Dixon J., Kaiser U.B., Slaugenhaupt S.A., Gusella J.F., O'Rahilly S., Carlton M.B., Crowley W.F., Aparicio S.A., Colledge W.H. The GPR54 gene as a regulator of puberty. N. Engl. J. Med. 2003, 349:1614-1627.
101. Seminara S.B., Dipietro M.J., Ramaswamy S., Crowley W.F., Plant T.M. Continuous human metastin 45-54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications. Endocrinology 2006, 147:2122-2126.
102. Semple R.K., Achermann J.C., Ellery J., Farooqi I.S., Karet F.E., Stanhope R.G., O'Rahilly S., Aparicio S.A. Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 2005, 90:1849-1855.
103. Shahab M., Mastronardi C., Seminara S.B., Crowley W.F., Ojeda S.R., Plant T.M. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2129-2134.
104. Silveira L.F., Stewart P.M., Thomas M., Clark D.A., Bouloux P.M., MacColl G.S. Novel homozygous splice acceptor site GnRH receptor (GnRHR) mutation: human GnRHR " knockout" J. Clin. Endocrinol. Metab. 2002, 87:2973-2977.
105. Silveira L.F.G., Santos M.A.G., Brito V.N., Silveira-Neto A.P., Moulatlet A.C.B., Cukiert P., Arnhold I.J.P., Mendonca B.B., Kaiser U.B., Latronico A.C. Two KiSS1 mutations in children with gonadotropin-dependent precocious puberty. 1st World Conference on Kisspeptin Signaling in the Brain 2008.
106. Smith J.T., Clarke I.J. Kisspeptin expression in the brain: catalyst for the initiation of puberty. Rev. Endocr. Metab. Disord. 2007, 8:1-9.
107. Soderlund D., Canto P., de la Chesnaye E., Ulloa-Aguirre A., Mendez J.P. A novel homozygous mutation in the second transmembrane domain of the gonadotrophin releasing hormone receptor gene. Clin. Endocrinol. (Oxf.) 2001, 54:493-498.
108. Soussi-Yanicostas N., Faivre-Sarrailh C., Hardelin J.P., Levilliers J., Rougon G., Petit C. Anosmin-1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner. J. Cell Sci. 1998, 111(Pt 19):2953-2965.
109. Soussi-Yanicostas N., de Castro F., Julliard A.K., Perfettini I., Chedotal A., Petit C. Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons. Cell 2002, 109:217-228.
110. Sulem P., Gudbjartsson D.F., Rafnar T., Holm H., Olafsdottir E.J., Olafsdottir G.H., Jonsson T., Alexandersen P., Feenstra B., Boyd H.A., Aben K.K., Verbeek A.L., Roeleveld N., Jonasdottir A., Styrkarsdottir U., Steinthorsdottir V., Karason A., Stacey S.N., Gudmundsson J., Jakobsdottir M., Thorleifsson G., Hardarson G., Gulcher J., Kong A., Kiemeney L.A., Melbye M., Christiansen C., Tryggvadottir L., Thorsteinsdottir U., Stefansson K. Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche. Nat. Genet. 2009.
111. Teles M.G.M., Trarbach E.B., Guerra G., Costa E.M.F., Baptista M.T.M., Castro M., Mendonca B.B., Kaiser U.B., Latronico A.C. A novel splice site mutation in GPR54 in two siblings with normosmic isolated hypogonadotrophic hypogonadism. 89th Endocrine's Society Annual Meeting, Endocrine Society 2007.
112. Teles M.G., Bianco S.D., Brito V.N., Trarbach E.B., Kuohung W., Xu S., Seminara S.B., Mendonca B.B., Kaiser U.B., Latronico A.C. A GPR54-activating mutation in a patient with central precocious puberty. N. Engl. J. Med. 2008, 358:709-715.
113. Tenenbaum-Rakover Y., Commenges-Ducos M., Iovane A., Aumas C., Admoni O., de Roux N. Neuroendocrine phenotype analysis in five patients with isolated hypogonadotropic hypogonadism due to a L102P inactivating mutation of GPR54. J. Clin. Endocrinol. Metab. 2007, 92:1137-1144.
114. Terasawa E., Fernandez D.L. Neurobiological mechanisms of the onset of puberty in primates. Endocr. Rev. 2001, 22:111-151.
115. Thompson E.L., Patterson M., Murphy K.G., Smith K.L., Dhillo W.S., Todd J.F., Ghatei M.A., Bloom S.R. Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J. Neuroendocrinol. 2004, 16:850-858.
116. Topaloglu A.K., Reimann F., Guclu M., Yalin A.S., Kotan L.D., Porter K.M., Serin A., Mungan N.O., Cook J.R., Ozbek M.N., Imamoglu S., Akalin N.S., Yuksel B., O'Rahilly S., Semple R.K. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat. Genet. 2009, 41:354-358.
117. Trarbach E.B., Silveira L.G., Latronico A.C. Genetic insights into human isolated gonadotropin deficiency. Pituitary 2007.
118. Trarbach E.B., Teles M.G., Costa E.M., Abreu A.P., Garmes H.M., Guerra G., Baptista M.T., de Castro M., Mendonca B.B., Latronico A.C. Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation-dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1. Clin. Endocrinol. (Oxf.) 2009.
119. Tsai P.S., Gill J.C. Mechanisms of disease: insights into X-linked and autosomal-dominant Kallmann syndrome. Nat. Clin. Pract. Endocrinol. Metab. 2006, 2:160-171.
120. Vermeulen S., Messiaen L., Scheir P., De Bie S., Speleman F., De Paepe A. Kallmann syndrome in a patient with congenital spherocytosis and an interstitial 8p11.2 deletion. Am. J. Med. Genet. 2002, 108:315-318.
121. Vissers L.E., van Ravenswaaij C.M., Admiraal R., Hurst J.A., de Vries B.B., Janssen I.M., van der Vliet W.A., Huys E.H., de Jong P.J., Hamel B.C., Schoenmakers E.F., Brunner H.G., Veltman J.A., van Kessel A.G. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat. Genet. 2004, 36:955-957.
122. Waldstreicher J., Seminara S.B., Jameson J.L., Geyer A., Nachtigall L.B., Boepple P.A., Holmes L.B., Crowley W.F. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J. Clin. Endocrinol. Metab. 1996, 81:4388-4395.
123. White B.J., Rogol A.D., Brown K.S., Lieblich J.M., Rosen S.W. The syndrome of anosmia with hypogonadotropic hypogonadism: a genetic study of 18 new families and a review. Am. J. Med. Genet. 1983, 15:417-435.
124. Wray S., Grant P., Gainer H. Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:8132-8136.
125. Zenteno J.C., Mendez J.P., Maya-Nunez G., Ulloa-Aguirre A., Kofman-Alfaro S. Renal abnormalities in patients with Kallmann syndrome. BJU Int. 1999, 83:383-386.